Prognostic Value of Plasma Biomarkers S100B and Osteopontin in Pediatric TBI: A Prospective Analysis Evaluating Acute and 6-Month Outcomes after Mild to Severe TBI

Prognostic Value of Plasma Biomarkers S100B and Osteopontin in Pediatric TBI: A Prospective Analysis Evaluating Acute and 6-Month Outcomes after Mild to Severe TBI

Blood based traumatic brain injury (TBI) biomarkers offer additional diagnostic, therapeutic, and prognostic utility. While adult studies are robust, the pediatric population is less well studied. We sought to determine whether plasma osteopontin (OPN) and S100B alone or in combination predict morta...

Full description

Bibliographic Details
Main Authors: Laura S. Blackwell, Bushra Wali, Yijin Xiang, Ali Alawieh, Iqbal Sayeed, Andrew Reisner
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomedicines
Subjects:
pediatric
biomarker
traumatic brain injury
outcomes
Online Access:https://www.mdpi.com/2227-9059/11/8/2167

Internet

https://www.mdpi.com/2227-9059/11/8/2167

Similar Items